26EHSKACLMSYRFA: RFA for Fee-for-Service Claims for Syringes

The Massachusetts Executive Office of Health and Human Services (EOHHS) issued this Request for Application (RFA) on February 6, 2026, seeking rebate agreements from syringe manufacturers to supply products through pharmacy fee-for-service claims for MassHealth members and Health Safety Net patients. The procurement covers syringes dispensed through the Pharmacy Online Processing System (POPS) to MassHealth Primary Care Clinician Plan enrollees, Health Safety Net patients, and members of participating MassHealth Managed Care Organizations and Accountable Care Partnership Plans. Applicants must submit a signed State Rebate Agreement with Attachment A specifying proposed per-unit Guaranteed Net Unit Prices (GNUP) for each National Drug Code, a cover letter documenting relevant experience as a preferred syringe manufacturer for state Medicaid programs within the past five years and clinical benefits information, and designated representative contact details. The GNUP shall be calculated as Wholesale Acquisition Cost (WAC) minus the rebate amount on a per-unit basis, with automatic recalculation if WAC changes while GNUP remains constant. EOHHS will evaluate applications based on prior experience serving as a preferred syringe manufacturer for Medicaid programs, clinical benefits, proposed GNUP rates, and other value considerations rather than lowest price alone. The deadline for submission is March 27, 2026, at 5:00 PM via email to EOHHS-Procurement@mass.gov, with an anticipated contract start date of January 1, 2027, for an initial 24-month term extendable at EOHHS's discretion for up to three additional years.

The RFA does not specify set-aside designations or restrictions limiting which organizations may respond, though applicants must demonstrate experience as preferred syringe manufacturers for state Medicaid programs. No incumbent vendors or current contractors are identified in the solicitation documents. Historical utilization data from calendar year 2024 indicates approximately 9,900 fee-for-service claims from approximately 4,720 members or patients, and approximately 10,490 managed care claims from approximately 4,840 members, though EOHHS makes no warranty regarding particular volumes during the agreement term. Manufacturers must ensure providers can purchase covered syringes below WAC, publish WAC with First Data Bank or other CMS-designated price compendiums, and comply with rebate payment terms requiring manufacturers to pay invoices within 38 days of receipt. EOHHS reserves the right to enter into agreements with one or more manufacturers based on best value determinations and retains the authority to modify any agreement provision at its sole discretion to reflect changes in policy, program goals, state or federal requirements, or judicial orders with written notice and negotiation with the manufacturer. Specific award values or budget ranges are not disclosed in the available solicitation documents.